Literature DB >> 20798784

Increased cytochrome c correlates with poor survival in aggressive lymphoma.

Sarah T Wilkinson1, David B F Johnson, Heather L Tardif, Margaret E Tome, Margaret M Briehl.   

Abstract

Mitochondria are central to a variety of cellular processes, from metabolism to cell death. In this study, we demonstrated that an increase in the critical mitochondrial protein, cytochrome c, correlated with drug resistance in a cell culture model of aggressive lymphoma. Increased cytochrome c expression was also correlated with decreased survival in the aggressive diffuse large B-cell and mantle cell lymphomas, but not in the indolent follicular lymphoma. This suggests that an increased reliance on the mitochondria for energy allows tumor cells to be metabolic opportunists and contribute to tumor development and drug resistance.

Entities:  

Year:  2010        PMID: 20798784      PMCID: PMC2927837          DOI: 10.3892/ol_00000040

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  14 in total

Review 1.  Mitochondria: releasing power for life and unleashing the machineries of death.

Authors:  Donald D Newmeyer; Shelagh Ferguson-Miller
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

2.  Overexpression of catalase or Bcl-2 alters glucose and energy metabolism concomitant with dexamethasone resistance.

Authors:  Margaret E Tome; Norbert W Lutz; Margaret M Briehl
Journal:  Biochim Biophys Acta       Date:  2004-07-23

Review 3.  Equilibration of adenylates in the mitochondrial intermembrane space maintains respiration and regulates cytosolic metabolism.

Authors:  Abir U Igamberdiev; Leszek A Kleczkowski
Journal:  J Exp Bot       Date:  2006-06-23       Impact factor: 6.992

Review 4.  Mitochondria in cancer: not just innocent bystanders.

Authors:  Christian Frezza; Eyal Gottlieb
Journal:  Semin Cancer Biol       Date:  2008-12-03       Impact factor: 15.707

5.  Isolation of human cell lines lacking mitochondrial DNA.

Authors:  M P King; G Attardi
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

6.  A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis.

Authors:  Margaret E Tome; David B F Johnson; Lisa M Rimsza; Robin A Roberts; Thomas M Grogan; Thomas P Miller; Larry W Oberley; Margaret M Briehl
Journal:  Blood       Date:  2005-08-04       Impact factor: 22.113

7.  The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.

Authors:  Andreas Rosenwald; George Wright; Adrian Wiestner; Wing C Chan; Joseph M Connors; Elias Campo; Randy D Gascoyne; Thomas M Grogan; H Konrad Muller-Hermelink; Erlend B Smeland; Michael Chiorazzi; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Sarah Henrickson; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Emilio Montserrat; Francesc Bosch; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Richard I Fisher; Thomas P Miller; Michael LeBlanc; German Ott; Stein Kvaloy; Harald Holte; Jan Delabie; Louis M Staudt
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

8.  Thymocytes selected for resistance to hydrogen peroxide show altered antioxidant enzyme profiles and resistance to dexamethasone-induced apoptosis.

Authors:  M E Tome; M M Briehl
Journal:  Cell Death Differ       Date:  2001-09       Impact factor: 15.828

9.  Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth.

Authors:  M E Tome; A F Baker; G Powis; C M Payne; M M Briehl
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

10.  Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.

Authors:  Sandeep S Dave; George Wright; Bruce Tan; Andreas Rosenwald; Randy D Gascoyne; Wing C Chan; Richard I Fisher; Rita M Braziel; Lisa M Rimsza; Thomas M Grogan; Thomas P Miller; Michael LeBlanc; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Joseph M Connors; Peter M Lansdorp; Qin Ouyang; T Andrew Lister; Andrew J Davies; Andrew J Norton; H Konrad Muller-Hermelink; German Ott; Elias Campo; Emilio Montserrat; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Liming Yang; John Powell; Hong Zhao; Neta Goldschmidt; Michael Chiorazzi; Louis M Staudt
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

View more
  4 in total

Review 1.  Mitochondria and redox homoeostasis as chemotherapeutic targets.

Authors:  Margaret M Briehl; Margaret E Tome; Sarah T Wilkinson; Melba C Jaramillo; Kristy Lee
Journal:  Biochem Soc Trans       Date:  2014-08       Impact factor: 5.407

2.  The Impact of Age and Sex in DLBCL: Systems Biology Analyses Identify Distinct Molecular Changes and Signaling Networks.

Authors:  Afshin Beheshti; Donna Neuberg; J Tyson McDonald; Charles R Vanderburg; Andrew M Evens
Journal:  Cancer Inform       Date:  2015-12-10

3.  Mitochondrial adaptations to oxidative stress confer resistance to apoptosis in lymphoma cells.

Authors:  Sarah T Wilkinson; Margaret E Tome; Margaret M Briehl
Journal:  Int J Mol Sci       Date:  2012-08-16       Impact factor: 6.208

4.  Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL.

Authors:  Kavita Bhalla; Sausan Jaber; Nanaji Nahid M; Karen Underwood; Afshin Beheshti; Ari Landon; Binny Bhandary; Paul Bastian; Andrew M Evens; John Haley; Brian Polster; Ronald B Gartenhaus
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.